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Crucial Step in Cholesterol Homeostasis: Sterols
Promote Binding of SCAP to INSIG-1, a Membrane
Protein that Facilitates Retention of SREBPs in ER
ning helices (Nohturfft et al., 1998b) and a long COOH-
terminal extension that contains multiple copies of a
WD40 repeat sequence, which forms a propeller-like
structure that binds to the COOH-terminal domains of
the SREBPs, thereby permitting the escort function (Sa-
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kai et al., 1997, 1998). The NH2-terminal membrane do-University of Texas Southwestern Medical Center
main of SCAP supplies the sterol-sensing functionDallas, Texas 75390
(Brown and Goldstein, 1999).2 Institute for Systems Biology
The dual role of SCAP as escorter and sensor wasSeattle, Washington 98105
established by studies of mutant Chinese hamster ovary
cells (CHO cells) in tissue culture. In mutant cells that
lack SCAP (SRD-13A cells), the SREBPs are not es-Summary
corted to the Golgi, cholesterol synthesis does not oc-
cur, and the cells require exogenous cholesterol forUsing coimmunoprecipitation and tandem mass spec-
growth (Rawson et al., 1999). In mutant cells expressingtrometry, we identify INSIG-1 as an ER protein that
SCAP with either of two amino acid substitutions (D443Nbinds the sterol-sensing domain of SREBP cleavage-
or Y298C), the sterol-sensing function is lost, and theactivating protein (SCAP) and facilitates retention of
SCAP/SREBP complex moves to the Golgi even in thethe SCAP/SREBP complex in the ER. In sterol-
presence of sterols (Nohturfft et al., 1998a). These twodepleted cells, SCAP escorts SREBPs from ER to Golgi
substitutions occur in a region, termed the sterol-sens-for proteolytic processing, thereby allowing SREBPs
ing domain, that encompasses five of the eight mem-to stimulate cholesterol synthesis. Sterols induce
brane-spanning helices of SCAP (transmembrane seg-binding of SCAP to INSIG-1, as determined by blue
ments 2-6 [TM2-6]).native-PAGE, and this is correlated with the inhibition
Indirect evidence indicates that the sterol-dependentof SCAP exit from the ER. Overexpression of INSIG-1
retention of SCAP in the ER involves a SCAP bindingincreases the sensitivity of cells to sterol-mediated
protein that is present in limiting amounts (Yang et al.,inhibition of SREBP processing. Mutant SCAP(Y298C)
2000). The initial clue came from the observation thatfails to bind INSIG-1 and is resistant to sterol-mediated
overexpression of SCAP leads to noninhibitable SREBPinhibition of ER exit. By facilitating sterol-dependent
processing as though a protein required for ER retentionER retention of SCAP, INSIG-1 plays a central role in
is overwhelmed by saturating levels of SCAP (Hua etcholesterol homeostasis.
al., 1996a). Supporting evidence came from competition
experiments in which we overexpressed a segment ofIntroduction
SCAP, designated SCAP(TM1-6), that contains the ste-
rol-sensing domain (Yang et al., 2000). Expression ofThe synthesis of cholesterol and other membrane lipids
this segment prevented the retention of the endogenousin mammalian cells is regulated by the controlled trans-
SCAP/SREBP complex in the ER, apparently by compet-port of sterol regulatory element binding proteins
ing for binding to the putative retention protein. As a(SREBPs) from the endoplasmic reticulum (ER) to the
control, we used a shorter segment of SCAP, designated
Golgi complex. SREBPs are membrane bound transcrip-
SCAP(TM 1-5), which has an incomplete sterol-sensing
tion factors that activate more than a score of genes
domain. This protein failed to release the endogenous
encoding enzymes of lipid synthesis. Immediately after SCAP/SREBP complex from its retention site in the ER.
their translation on ER membranes, SREBPs bind to Mutant versions of SCAP(TM1-6) containing the Y298C
SREBP cleavage-activating protein (SCAP), a polytopic substitution also failed to release the SCAP/SREBP
membrane protein that serves both an escort function complex (Yang et al., 2000).
and a sterol-sensing function. In sterol-depleted cells, In the current study, we identified an ER protein that
SCAP escorts the SREBPs into budding vesicles that binds to the sterol-sensing domain of SCAP only in the
reach the Golgi complex where the SREBP is cleaved presence of sterols. For this purpose, we prepared lines
by two membrane bound proteases in a process called of permanently transfected cells that express epitope-
regulated intramembrane proteolysis (RIP) (Brown et al., tagged versions of SCAP(TM1-6) or the negative control
2000). These cleavages release the NH2-terminal seg- SCAP(TM1-5). Through affinity isolation and tandem
ment of the SREBP so that it can enter the nucleus. mass spectrometry analysis, we identify a protein, des-
When sterols overaccumulate in cells, SCAP is retained ignated INSIG-1, that fits these criteria. We provide evi-
in the ER, SREBP cannot be processed, and the synthe- dence that INSIG-1 is the postulated saturable protein
sis of cholesterol declines (Brown and Goldstein, 1999; that is required for the sterol-dependent retention of the
Goldstein et al., 2002). SCAP/SREBP complex in the ER.
SCAP contains two domains: an NH2-terminal mem-
brane attachment domain with eight membrane-span- Results
As vehicles for the chronic overexpression of3 Correspondence: joe.goldstein@utsouthwestern.edu (J.L.G.);mike.
brown@utsouthwestern.edu (M.S.B.) SCAP(TM1-6) and SCAP(TM1-5), we chose 293S cells,
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Figure 1. Characteristics of Human INSIG-1
(A) Amino acid sequence. The two peptides identified by mass spectrometry are boxed. Methionine-37 (denoted by asterisk) can be used as
an additional translational start site when INSIG-1 is overexpressed in transfected cells. Our sequence (GenBank accession number AY112745)
differs from that of Peng, et al. (1997) (GenBank accession number: NP_005533) at residues 27 (Ala versus Thr), 31 (Ala versus Pro), 32 (Ala
versus Pro), 99 (Ala versus Thr), 170 (Val versus Gly), and 172 (Val versus Gly). Our sequence is identical to that deposited in GenBank by R.
Stausberg, NIH (accession number: AAH01880). The human INSIG-1 amino acid sequence is 84.6% identical to that of the rat (Diamond et
al., 1993) (GenBank accession number: NP_071787) and 84.2% identical to that of the mouse (Celera database).
(B) Hydropathy plot. The residue-specific hydropathy index was calculated over a window of 17 residues by the method of Kyte and Doolittle
(1982) using software from DNASTAR, Inc.
(C) Northern blot analysis of INSIG-1 gene transcripts in multiple human tissues. Filters containing poly(A) RNA (2 g/lane) from multiple
human tissues (Clontech) were hybridized with a 32P-labeled probe against human INSIG-1 (1.5  106 cpm/ml) for 1 hr at 68C as described
in Supplemental Experimental Procedures available at http://www.cell.com/cgi/content/full/110/4/489/DC1. Filters were exposed to Kodak
XAR-5 film with intensifying screen at 80C for 48 hr. The same filter was subsequently hybridized with a 32P-labeled probe against human
-actin (1.5  106 cpm/ml) and exposed to film for 3 hr at 80C.
(D) Immunofluorescence localization of human INSIG-1 in stably transfected CHO cells. CHO/pINSIG-1-Myc cells were generated by transfection
of CHO-7 cells (Metherall et al., 1989) with pCMV-INSIG-1-Myc, followed by selection in medium C containing 5% FCS, 5 g/ml cholesterol,
1 mM sodium mevalonate, 20 M sodium oleate, and 700 g/ml G418. Surviving colonies were isolated with cloning cylinders, expanded,
screened for expression of INSIG-1-Myc by immunoblot analysis, and subjected to a second round of cloning by limiting dilution. On day 0,
cells were seeded onto coverslips (4  104 cells/37 mm well) in medium C supplemented with 5% FCS, 5 g/ml cholesterol, 1 mM sodium
mevalonate, and 20 M sodium oleate. On day 2, the cells were washed twice with PBS and switched to medium D in the absence (no sterols)
or presence of 1 g/ml of 25-HC plus 10 g/ml of cholesterol ( sterols). On day 3, the cells were fixed, and indirect immunofluorescence
was performed as described (Nohturfft et al., 2000). Anti-Myc IgG-9E10 (10 g/ml) was visualized with 15 g/ml of goat anti-mouse IgG
conjugated to Alexa 488 (Molecular Probes). Cells were imaged using a confocal microscope (Nohturfft et al., 2000). No signal was detected
in mock-transfected CHO-7 cells (data not shown). Bar equals 10 m.
a clone of human embryonic kidney 293 cells that can subjected to SDS-PAGE and stained with Coomassie
blue. Gel segments containing visible bands were ex-be grown to high density in suspension cultures (Reeves
et al., 1996). These cells were transfected with cDNAs cised and digested with trypsin, and the sequences of
the resultant peptides were determined by tandem massencoding truncated versions of SCAP corresponding to
TM1-6 and TM1-5. Each expressed SCAP protein had spectrometry. Extracts of cells expressing SCAP(TM1-6)
and SCAP(TM1-5) were processed in parallel except thattwo affinity tags at the NH2-terminus: a calmodulin bind-
ing peptide and a FLAG epitope. The cells were grown we loaded excess protein from the SCAP(TM1-5) cells
so as to aid in the exclusion of bands that are commonin suspension in the presence of 25-hydroxycholesterol
(25-HC), a sterol that causes SCAP to be retained in the to the SCAP(TM1-6) and SCAP(TM1-5) cells.
The affinity isolation procedure yielded 7 faintly visibleER (Nohturfft et al., 2000). Cell membranes were isolated
and solubilized with 0.5% Chapso, a detergent that effi- protein bands that were present in the SCAP(TM1-6)
lane and absent in the SCAP(TM1-5) lane (see Supple-ciently solubilizes SCAP. The extracts were then sub-
jected to sequential affinity chromatography using an mental Figure S1 available at http://www.cell.com/cgi/
content/full/110/4/489/DC1). Tandem mass spectrome-anti-FLAG antibody and calmodulin. The final eluate was
Sterols Promote Interaction of SCAP with INSIG-1
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Figure 2. Overexpression of INSIG-1 Blocks Processing of SREBP-1a and SREBP-2 in the Absence of Sterols without Affecting Transport
of VSVG
(A and B) On day 0, SRD-13A cells were set up in 60 mm dishes as described in Supplemental Experimental Procedures available at http://
www.cell.com/cgi/content/full/110/4/489/DC1. On day 2, the cells were transfected with the indicated plasmids as follows: 2 g of either pTK-
HSV-SREBP-1a (A) or pTK-HSV-SREBP-2 (B); 1 g of pTK-SCAP; and varying concentrations of pCMV-INSIG-1-Myc (10 ng in lanes 4 and
10, 25 ng in lanes 5 and 11, and 75 ng in lanes 2, 6, 8, and 12). Six hr after transfection, cells were switched to medium D, incubated for 16
hr, and harvested. Aliquots of nuclear extracts (representing 1.5 dishes of cells) and membranes (0.5 dish for immunoblot of SREBP precursor
and 1.5 dishes for SCAP and INSIG-1) were subjected to SDS-PAGE (8% gels and 12% gels, respectively) and immunoblot analysis with 67
ng/ml anti-HSV IgG (SREBPs), 5 g/ml anti-SCAP IgG-R139, or 3 g/ml anti-Myc IgG-9E10 (INSIG-1) as indicated. N and P denote cleaved
nuclear and uncleaved precursor forms of HSV epitope-tagged SREBP-1a or SREBP-2, respectively. Filters were exposed to film for  1 min
for the anti-HSV and anti-Myc blots and 1–2 min for the anti-SCAP blot.
(C and D) On day 0, SRD-13A cells were set up in 100 mm dishes. On day 2, the cells were transfected with the indicated plasmids as follows:
2 g of pTK-HSV-SREBP-2; 1 g of pTK-SCAP; 0.4 g of pCMV-VSVG-T7; and varying concentrations of pCMV-INSIG-1-Myc as indicated.
Transfection was carried out in the presence of 5% lipoprotein-deficient serum. Five hr after transfection, cells were switched to medium D
and incubated for 12 hr at 40C. One-half of the dishes were refed with fresh medium warmed at 32C, and the other half were kept at 40C.
After incubation for 3 hr at the indicated temperature, the cells were chilled on ice and then harvested. Aliquots of nuclear extracts (representing
0.5 dish) and membranes (0.6 dish in C; 0.2 dish in D) were subjected to SDS-PAGE and immunoblot analysis as above. VSVG was detected
with 1 g/ml of anti-T7 IgG. Filters were exposed to films for 1–2 min. VGO and VER denote Golgi-modified and ER forms of VSVG-T7, respectively.
N and P denote cleaved nuclear and uncleaved precursor forms of HSV epitope-tagged SREBP-2, respectively.
try analysis yielded sequences of at least two different Figure 1A shows the amino acid sequence of human
INSIG-1 as deduced from a cDNA obtained through PCRpeptides corresponding to a single protein for each of
the 7 bands. The identities of these proteins are given of a cDNA library prepared from human HepG2 cell
mRNA. The two peptides identified by mass spectrome-in the legend to the Figure in Supplemental Experimental
Procedures available at above URL. One of the proteins, try are indicated. Figure 1B shows a hydropathy plot of
human INSIG-1. The sequence suggests at least sixINSIG-1, was chosen for further study because earlier
studies in our laboratory had identified INSIG-1 as an membrane-spanning regions. Northern blot analysis re-
veals expression of INSIG-1 in every human tissue thatelevated mRNA in livers of transgenic mice that overex-
press SREBP-1a (Luong, 2000). The other identified pro- was tested. Expression was especially high in the liver
(Figure 1C). Immunofluorescence of epitope-tagged IN-teins were not investigated further, and we have no
information as to whether their presence reflects a func- SIG-1 in stably transfected CHO cells showed an ER
localization when the cells were cultured in either thetional interaction with SCAP(TM1-6).
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Figure 3. INSIG-1 Restores Sterol-Mediated Inhibition of SREBP-2 Cleavage in Cells Overexpressing SCAP: Reversal by Brefeldin A
On day 0, SRD-13A cells were set up in 100 mm dishes. On day 2, the cells were transfected with 2 g of pTK-HSV-SREBP-2 and other
plasmids as indicated. Twelve hr after transfection, cells were washed with PBS and switched to medium D containing 1% (w/v) hydroxypropyl-
-cyclodextrin (HPCD). After incubation for 1 hr at 37C, the cells were washed twice with PBS and switched to medium D in the absence or
presence of 1 g/ml of 25-hydroxycholesterol (25-HC) plus 10 g/ml cholesterol (sterols).
(A) After incubation for 4 hr in the absence or presence of sterols, cells were harvested for preparation of nuclear extract and membrane
fractions. Aliquots of nuclear extracts (representing 0.5 dish of cells) and membranes (0.2 dish for SREBP-2 precursor and 0.6 dish for SCAP
and INSIG-1) were subjected to SDS-PAGE and immunoblot analysis as described in Figure 3. N and P denote cleaved nuclear and uncleaved
precursor forms of HSV epitope-tagged SREBP-2, respectively. Filters were exposed to films for 5 s (SREBP-2 and INSIG-1) or 1 min (SCAP).
(B) After incubation for 4 hr in the absence of sterols, each dish received a direct addition of brefeldin A in ethanol (final concentration, 1 g/
ml brefeldin A; 0.1% ethanol). After incubation for 5 hr, cells were harvested for preparation of nuclear extract and membrane fractions and
subjected to SDS-PAGE and immunoblot analysis as in (A). Asterisk (*) denotes a crossreacting band. Filters were exposed to film for 1 min
(SREBP-2 and SCAP) or 1 s (INSIG-1).
absence or presence of sterols (Figure 1D). Inasmuch We used a T7 epitope-tagged temperature sensitive ver-
sion of VSVG that exits the ER at 32C, but not at 40Cas the INSIG-1 was overexpressed, we cannot rule out
the possibility of a Golgi localization for a minor fraction (Nohturfft et al., 2000; Bergmann, 1989). ER to Golgi
movement of VSVG is reflected by a decrease in mobilityof the protein.
To test the hypothesis that INSIG-1 regulates the on SDS-PAGE, owing to sialylation (Bergmann, 1989).
At 40C, the faster mobility of VSVG was consistent withmovement of SCAP and thus the processing of SREBP,
we used mutant hamster SRD-13A cells that do not an ER localization (lanes 2 and 10), whereas at 32C,
the slower mobility suggested a Golgi localization (laneexpress SCAP, owing to defects in both copies of the
SCAP gene. We transfected these cells with a cDNA 1). Overexpression of SCAP had no effect either at 40C
(lane 2) or 32C (lane 3). Likewise, overexpression ofencoding SCAP under control of the weak thymidine
kinase (TK) promoter, which produces relatively small INSIG-1 had no effect at either temperature (lanes 4–9).
As a positive control in the same experiment, we showedamounts of SCAP. We also transfected cDNAs encoding
epitope-tagged SREBP-1a (Figure 2A) and SREBP-2 that INSIG-1 blocked SREBP-2 processing at both tem-
peratures (Figure 2D).(Figure 2B). In the absence of SCAP, there was no pro-
cessing of SREBP-1a or SREBP-2 (lanes 1 and 7), and The experiments of Figure 2 were performed in sterol-
deprived cells that markedly overexpress epitope-INSIG-1 had no effect (lanes 2 and 8). Expression of
SCAP gave a big increase in nuclear SREBP-1a and tagged INSIG-1. The data indicate that INSIG-1 can
block SREBP processing even in the absence of exoge-SREBP-2 (lanes 3 and 9). Overexpression of epitope-
tagged INSIG-1 completely blocked this processing nous sterols when the ratio of INSIG-1 to SCAP is high.
Figure 3A shows an experiment in which we expressed(lanes 4–6 and 10–12). The amounts of membrane bound
SREBP precursors were not affected. Immunoblots of two different levels of SCAP: a relatively low level
through the use of the weak TK promoter and a 10-foldepitope-tagged INSIG-1 revealed two bands. In experi-
ments not shown, we found that the larger protein results higher level through the use of the strong CMV promoter.
We transfected the SRD-13A cells without or with 200from translation initiation at residue 1 as shown in Figure
1A. The smaller band comes from initiation at residue ng of a cDNA encoding INSIG-1. All of the cells also
received a plasmid encoding HSV-tagged SREBP-2. The37 (denoted by asterisk in Figure 1A).
To test for the specificity of the INSIG-1 inhibition cells were incubated in the absence or presence of ste-
rols (25-HC plus cholesterol) and assayed for SREBPof SCAP/SREBP transport, we measured the ability of
INSIG-1 to block the movement of the vesicular stomati- processing as monitored by the amount of nuclear
SREBP-2. Low levels of SCAP expression enhancedtis virus G protein (VSVG) from ER to Golgi (Figure 2C).
Sterols Promote Interaction of SCAP with INSIG-1
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Figure 4. Formation of INSIG-1/SCAP Com-
plex: Detection by Blue Native-PAGE
On day 0, SRD-13A cells were set up in 100
mm dishes. On day 2, the cells were trans-
fected with the indicated plasmids as follows:
2 g of pTK-HSV-SREBP-2; 4 g of pCMV-
SCAP; and 60 ng of pCMV-INSIG-1-Myc.
Twelve hr after transfection, cells were
washed and switched to medium D con-
taining 1% HPCD. After incubation for 1 hr at
37C, the cells were washed and switched to
medium D in the absence or presence of 1g/
ml of 25-HC plus 10 g/ml of cholesterol (ste-
rols). After incubation for 4 hr, cells from 4
dishes were pooled for measurement of
SCAP/INSIG-1 complex formation by BN-
PAGE and immunoblot analysis as described
in Experimental Procedures. In lanes 5–8, su-
pershift assays were carried out with 2 g
control mouse monoclonal IgG-2001 (control
Ab) (lanes 5 and 7) or 2 g monoclonal anti-
SCAP IgG-9D5 (lanes 6 and 8). Filters were
exposed to film for 1 s for lanes 1–4 and 15
s for lanes 5–8. Digitonin-solubilized extracts
from lanes 1–4 were also subjected to SDS-
PAGE and immunoblot analysis with 5 g/
ml of anti-SCAP IgG-R139 or 0.33 g/ml of
polyclonal anti-Myc IgG (INSIG-1). Filters
were exposed to films for 1 s.
SREBP-2 processing (lane 2), and this was blocked by processing (lane 5) even though the experiment was
conducted in the absence of exogenous sterols. Brefel-sterols (lane 3). Under these low-SCAP conditions, IN-
SIG-1 inhibited SREBP-2 processing in the absence or din A overcame this block (lane 6), supporting the idea
that INSIG-1 acts by facilitating retention of the SCAP/presence of sterols (lanes 4 and 5). A different result
was obtained when excess SCAP was produced with the SREBP complex in the ER.
To directly search for a complex between SCAP andCMV promoter. Under these conditions, as previously
described (Hua et al., 1996a; Rawson et al., 1999), sterols INSIG-1, we used the technique of blue native-polyacryl-
amide gel electrophoresis (BN-PAGE) that was devel-no longer suppressed SREBP-2 cleavage (lanes 6 and
7). Expression of INSIG-1 had no effect on SREBP-2 oped by Schagger et al. (1994) for the resolution of
native membrane proteins. Cells were transfected withprocessing in the absence of sterols (lane 8), but it re-
stored sterol regulation (lane 9). These results are con- a plasmid encoding Myc-tagged INSIG-1. Isolated mem-
branes were solubilized with digitonin, and the superna-sistent with the notion that INSIG-1 is the ER protein
that is saturated when SCAP is overexpressed via the tants were treated with Coomassie blue, which imparts
a negative charge, and 6-amino-n-hexanoic acid, whichCMV promoter. The INSIG-1 cDNA restores an excess
of INSIG-1 and thereby allows sterols to cause SCAP helps to keep the proteins in solution. After PAGE in a
discontinuous solvent system, the proteins were trans-retention in the ER. If the ratio of INSIG-1 to SCAP is
too high, the SCAP is retained in the ER even in the ferred to a PVDF membrane and incubated with an anti-
body against the Myc tag on INSIG-1. As shown in Figureabsence of exogenous sterols, as in lanes 4 and 5 of
Figure 3A. 4, free INSIG-1 is visualized as a primary band (desig-
nated unbound INSIG-1 in Figure) and a diffuse tail thatIf INSIG-1 is blocking SREBP processing by retaining
SCAP in the ER, the block should be relieved by brefeldin extends upward in the gel (lane 1). This pattern was not
affected by sterols in the absence of SCAP (lane 2).A, a compound that causes Golgi proteins to accumulate
in the ER (Lippincott-Schwartz et al., 1989). Previous When SCAP was coexpressed, the amount of unbound
INSIG-1 was partially reduced, and a discrete band wasstudies showed that brefeldin A overcomes the sterol
block in SREBP processing by causing the Site-1 prote- revealed at a higher position (designated SCAP/INSIG-1
complex; lane 3). The addition of sterols caused a com-ase (and probably the Site-2 protease) to move to the
ER where they can cleave SREBPs without any require- plete disappearance of unbound INSIG-1 and a further
increase in the SCAP/INSIG-1 complex (lane 4).ment for SCAP (DeBose-Boyd et al., 1999). We therefore
transfected SRD-13A cells with pTK-SCAP plus pCMV- To show that the complex contained SCAP as well as
INSIG-1, we performed an antibody supershift experi-INSIG-1 and then incubated these cells with brefeldin
A (Figure 3B). As expected, INSIG-1 blocked SREBP-2 ment. Digitonin-solubilized extracts were prepared from
Cell
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Figure 5. Complete Inhibition of SREBP-2 Processing by Sterols Requires an Excess of INSIG-1
(A) On day 0, SRD-13A cells were set up in 100 mm dishes. On day 2, the cells were transfected with the indicated plasmids as follows: 2 g
of pTK-HSV-SREBP-2; 2 g of pCMV-SCAP (lanes 3–15); and varying concentrations of pCMV-INSIG-1-Myc as indicated. Twelve hr after
transfection, cells were washed and switched to medium D containing 1% HPCD. After incubation for 1 hr at 37C, the cells were washed
and switched to medium D in the absence () of presence () of 1 g/ml of 25-HC plus 10 g/ml of cholesterol (sterols). After incubation for
4 hr, cells from 1 dish were harvested for preparation of nuclear extract and membrane fractions. Aliquots of nuclear extracts (representing
0.5 dish) and membranes (0.6 dish) were subjected to SDS-PAGE and immunoblot analysis as described in Figure 3. Filters were exposed to
films for 1–3 s.
(B) Cells from 3 dishes of the same transfection in (A) were pooled for measurement of SCAP/INSIG-1 complex formation by BN-PAGE and
immunoblot analysis. The amount of extract applied to the gel was inversely proportional to the amount of INSIG-1 plasmid transfected. The
unbound INSIG-1 not complexed with SCAP is shown. Filters were exposed to film for 2 s.
(C) Quantification of SREBP-2 cleavage in relation to amount of unbound INSIG-1 not complexed with SCAP. Immunoblots of nuclear extract
in (A) and unbound INSIG-1 in (B) were scanned and quantified by densitometry. The ratio of the intensity of bands in the presence and
absence of sterols for SREBP-2 cleavage (H17009) and unbound INSIG-1 () are plotted.
sterol-treated cells and incubated with an antibody nuclear SREBP-2 (A, lanes 1 and 2). Overproduction of
SCAP without INSIG-1 led to SREBP-2 processing thatagainst SCAP prior to PAGE (Figure 4, lanes 5–8). In the
absence of SCAP cotransfection, the anti-SCAP anti- was not inhibited by sterols (lanes 3 and 4). At low levels
of INSIG-1, there was little sterol inhibition (lanes 5–8).body had no effect on the migration of unbound INSIG-1
(lanes 5 and 6). When SCAP was overexpressed, we However, at higher INSIG-1 levels, there was clear sup-
pression by sterols (lanes 9–14). At low levels of INSIG-1,visualized the band designated SCAP/INSIG-1 complex,
and its migration was not affected when the extracts the amount of unbound INSIG-1 was markedly de-
creased by sterols as measured by BN-PAGE (B, laneswere incubated with a control monoclonal antibody (lane
7). However, when the extracts were incubated with the 3–6). However, at higher INSIG-1 concentrations, most
of the INSIG-1 remained unbound after sterol additionanti-SCAP antibody, the complex migrated more slowly
on the gel (supershifted complex in lane 8). These data (lanes 7–12). Figure 5C plots the amount of nuclear
SREBP-2 and the amount of unbound INSIG-1 in theindicate that INSIG-1 forms a complex with SCAP and
that the formation of the complex is enhanced by sterols. presence of sterols, each divided by the amount in the
absence of sterols. At low INSIG-1 levels, SREBP-2To confirm the stoichiometric relationship between
INSIG-1 and SCAP, we performed an INSIG-1 titration cleavage is high, and it falls as the INSIG-1 level rises,
which reflects the sterol-induced inhibition of SREBP-2experiment (Figure 5). SRD-13A cells were transfected
with cDNAs encoding HSV-tagged SREBP-2, a large cleavage. The relative amount of unbound INSIG-1 rises
in inverse proportion to the SREBP-2 cleavage. Theseamount of SCAP, and varying amounts of INSIG-1. The
cells were incubated in the absence and presence of data indicate that SREBP-2 cleavage is blocked by ste-
rols only when there is excess unbound INSIG-1 avail-sterols and harvested for measurement of the amounts
of nuclear SREBP-2 and unbound INSIG-1. The amount able so that it can bind all of the SCAP/SREBP-2 com-
plex. When INSIG-1 is limiting, sterols cause all of theof protein applied to the BN-PAGE was adjusted in-
versely to the amount of INSIG-1 plasmid transfected INSIG-1 to bind to SCAP, leaving behind a pool of un-
bound SCAP to transport SREBPs.in order to keep the total amount of INSIG-1 applied to
the gel constant. In the absence of SCAP, there was no As discussed above, mutant SCAP(Y298C) fails to be
Sterols Promote Interaction of SCAP with INSIG-1
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Figure 6. Reduced Interaction of INSIG-1
with Sterol-Resistant Mutant SCAP(Y298C)
(A) On day 0, SRD-13A cells were set up in
60 mm dishes. On day 2, the cells were trans-
fected with the indicated plasmids as follows:
2 g of pTK-HSV-SREBP-2; 1 g of pTK-
SCAP (wild-type, lanes 2–5); 1 g of pTK-
SCAP (Y298C, lanes 6–9); and varying con-
centrations of pCMV-INSIG-1-Myc (10 ng in
lanes 3 and 7, 25 ng in lanes 4 and 8, and 50
ng in lanes 5 and 9). Six hr after transfection,
cells were switched to medium D, incubated
for 16 hr, and harvested. Aliquots of nuclear
extracts (representing 1.5 dishes of cells) and
membranes (0.5 dish for SREBP precursor
and 1.5 dish for SCAP and INSIG-1) were sub-
jected to SDS-PAGE and immunoblot analy-
sis as described in Figure 2. N and P denote
cleaved nuclear and uncleaved precursor
forms of HSV epitope-tagged SREBP-2, re-
spectively. Filters were exposed to film for
1 s for anti-HSV (SREBPs) and anti-Myc
(INSIG-1) blots and 5 s for the anti-SCAP blot.
(B) On day 0, SRD-13A cells were set up in
100 mm dishes. On day 2, the cells were
transfected with the indicated plasmids as
follows: 2 g of pTK-HSV-SREBP-2; 1 g of
pCMV-SCAP (wild-type, lanes 2–3); 0.2 g
of pCMV-INSIG-1-Myc; and 1 g of pCMV-
SCAP (Y298C, lanes 4–5) as indicated. Twelve
hr after transfection, cells were switched to
medium D containing 1% HPCD. After incu-
bation for 1 hr at 37C, the cells were washed
and switched to medium D in the presence
of 0.1g/ml of 25-HC plus 10g/ml of choles-
terol (sterols). After incubation for 4 hr at 37C,
cells were harvested for preparation of nu-
clear extract and membrane fractions. Ali-
quots of nuclear extracts (0.5 dish of cells)
and membranes (0.2 dish for SREBP-2 pre-
cursor and 0.6 dish for SCAP and INSIG-1)
were subjected to SDS-PAGE and immu-
noblot analysis. Filters were exposed to films
for 5 s.
(C) On day 0, SRD-13A cells were set up in 100 mm dishes. On day 2, the cells were transfected with the indicated plasmids as follows: 2
g of pTK-HSV-SREBP-2; 60 ng of pCMV-INSIG-1-Myc; 4 g of pCMV-SCAP (wild-type, lane 3); and 4 g of pCMV-SCAP (Y298C, lane 4).
Additions to medium and incubations were the same as in panel B. Cells from 4 dishes were pooled for measurement of SCAP/INSIG-1
complex formation by BN-PAGE and immunoblot analysis. Filters were exposed to films for 4 s. Digitonin-solubilized extracts from lanes 1–4
were also subjected to SDS-PAGE and immunoblot analysis with 5 g/ml of anti-SCAP IgG-139 and 0.33 g/ml of polyclonal anti-Myc IgG
(INSIG-1). Filters were exposed to films for 20 s.
retained in the ER upon sterol addition. When SRD-13A sence of INSIG-1, 25-hydroxycholesterol reduced
SREBP-2 cleavage by a maximum of 50% at 250 nM.cells were transfected with a cDNA encoding mutant
SCAP(Y298C), expression of INSIG-1 had no effect on In the presence of INSIG-1, cleavage of SREBP-2 was
reduced by 50% in the presence of cholesterol andSREBP-2 processing either at low SCAP levels in the
absence of sterols (Figure 6A) or at high SCAP levels in the absence of 25-hydroxycholesterol. Addition of small
amounts of 25-hydroxycholesterol further decreasedthe presence of sterols (Figure 6B). Moreover, mutant
SCAP failed to form a complex with INSIG-1 as deter- SREBP-2 processing with 90% inhibition at 25 nM. IN-
SIG-1 also increased the sensitivity of SREBP-2 pro-mined by BN-PAGE (Figure 6C). These data are consis-
tent with the notion that the sterol-resistance of the cessing to inhibition by cholesterol delivered in LDL
(Figures 7C and 7D). In a separate experiment, we foundY298C mutant is attributable to its failure to bind
INSIG-1. that INSIG-1 increased the sensitivity to inhibition by
cholesterol delivered in ethanol. In the presence of IN-To determine whether INSIG-1 increases the sensitiv-
ity of SREBP-2 processing to inhibition by 25-hydroxy- SIG-1, nuclear SREBP-2 declined by 50% at a choles-
terol concentration of 9 M, whereas in the absence ofcholesterol, we transfected cells with a plasmid encod-
ing TK-driven SCAP and a small amount of a plasmid INSIG-1 cholesterol caused no inhibition at 26 M (data
not shown).encoding INSIG-1 (Figures 7A and 7B). The cells were
incubated in the presence of 26 M cholesterol and To test for the presence of a ternary complex of
SREBP, SCAP, and INSIG-1, we performed the immuno-increasing amounts of 25-hydroxycholesterol. In the ab-
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Figure 7. INSIG-1 Increases Sensitivity of SCAP to 25-Hydroxycholesterol (25-HC) and LDL
(A and C) On day 0, SRD-13A cells were set up in 100 mm dishes. On day 2, the cells were transfected with 2 g of pTK-HSV-SREBP-2 and
other plasmids as indicated. Twelve hr after transfection, cells were switched to medium D containing 1% HPCD and incubated for 1 hr at
37C. The cells were washed and switched to medium D in the presence of either 10 g/ml cholesterol plus the indicated concentration of
25-HC (A) or the indicated concentration of LDL (C). After incubation for 5 hr (A) or 7 hr (C) at 37C, cells were harvested for preparation of
nuclear extract and membrane fractions. Aliquots of nuclear extracts (representing 1 dish of cells) and membranes (0.2 dish for SREBP-2
precursor and 0.6 dish for SCAP and INSIG-1) were subjected to SDS-PAGE and immunoblot analysis as described in Figure 2. N and P
denote cleaved nuclear and uncleaved precursor forms of HSV epitope-tagged SREBP-2, respectively. Filters were exposed to film for 5 s
(A) and 1–2 min (C).
(B and D) The gels in (A) and (C) were scanned and quantified by densitometry. The intensity of the cleaved nuclear form of SREBP-2 in lanes
1 and 11 was arbitrarily set at 100%.
precipitation experiment of Figure 8. Cells were trans- tion of the SCAP/SREBP complex in the ER, thereby
decreasing cholesterol synthesis. The search for a re-fected with cDNAs encoding SCAP and epitope-tagged
versions of SREBP-2 and INSIG-1, and detergent ex- tention protein was triggered by the realization that the
retention process can be overcome by expression oftracts were prepared using Nonidet P40. Precipitation
with anti-SCAP brought down 50% of the SREBP-2 excess full-length SCAP (Hua et al., 1996a) or the TM1-6
fragment of SCAP (Yang et al., 2000), strongly sug-precursor and 25% of the larger form of INSIG-1 (lane
2). Similarly, precipitation with an antibody against the gesting that the retention protein exists in limited
amounts and is susceptible to saturation. Using tech-Myc epitope on INSIG-1 brought down 50% of SCAP
and 50% of the SREBP-2 precursor (lane 5). No niques of affinity isolation and tandem mass spectrome-
try, we identified several proteins that were coisolatedSREBP-2 precursor was precipitated by this antibody
when SCAP was omitted (lane 4), indicating that the with SCAP(TM1-6), but not SCAP(TM1-5) in the presence
of sterols. We focused on one of these proteins, INSIG-1,association of INSIG-1 with SREBP-2 required SCAP.
and obtained functional data showing that this protein
binds SCAP in a stoichiometric fashion and leads toDiscussion
its retention in the ER, thereby preventing proteolytic
processing of SREBPs.In the current studies, we identify and characterize an
ER membrane protein, INSIG-1, that binds SCAP in a The INSIG-1 mRNA was originally isolated in 1991 by
Taub and colleagues (Mohn et al., 1991; Diamond et al.,sterol-dependent fashion. We provide evidence that
INSIG-1 is responsible for the sterol-dependent reten- 1993), who identified it as an mRNA whose abundance
Sterols Promote Interaction of SCAP with INSIG-1
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the migration of INSIG-1 is retarded when cells express
SCAP (Figure 4). This retardation reflects the formation
of a SCAP/INSIG-1 complex as revealed by the further
retardation of the complex by incubation with anti-SCAP
(Figure 4, lane 8). The amount of the complex is in-
creased and unbound INSIG-1 disappears when the
cells are treated with sterols under conditions in which
the SCAP/SREBP complex is retained in the ER (Figure
4, lane 4). SCAP, INSIG-1, and SREBPs form a ternary
complex, as indicated by the coimmunoprecipitation
data in Figure 8.
The titration experiment of Figure 5 suggests that
SCAP and INSIG-1 form a stoichiometric complex in the
presence of sterols and that unbound INSIG-1 is present
only when the amount of INSIG-1 exceeds the amount
of SCAP. By the same token, in the presence of sterols
unbound SCAP should exist only when all INSIG-1 has
been occupied. If unbound SCAP is the only form of
SCAP that can carry SREBP to the Golgi, saturation of
INSIG-1 would explain the previous observation that
SREBP cleavage becomes resistant to inhibition by ste-
rols when SCAP is overexpressed (Hua et al., 1996a).
In recently reported studies, we showed that the addi-
tion of sterols to intact cells or to isolated cellular mem-
branes leads to a conformational change in SCAP as
revealed by the exposure of a cryptic arginine residue
to digestion by trypsin (Brown et al., 2002). As noted
previously, SCAP is present in a complex with SREBPs
either in the absence or presence of sterols (Sakai et
al., 1997, 1998). In the absence of sterols, the SCAP/
Figure 8. Coimmunoprecipitation of INSIG-1, SCAP, and SREBP-2
SREBP complex is free to exit the ER and reach thein Extracts from Transfected SRD-13A Cells
Golgi complex (DeBose-Boyd et al., 1999; Nohturfft etOn day 0, SRD-13A cells were set up in 100 mm dishes. On day 2,
al., 2000). When sterols accumulate, they bind to SCAPthe cells were transfected with the indicated plasmids as follows:
and cause a conformational change that increases the2 g of pTK-HSV-SREBP-2; 1 g of pCMV-SCAP; and 0.2 g of
pCMV-INSIG-1-Myc. Twelve hr after transfection, cells were washed affinity of SCAP for INSIG-1. The SREBP/SCAP/INSIG-1
and switched to medium D containing 1% HPCD. After incubation complex becomes trapped in the ER by a mechanism
for 1 hr at 37C, the cells were washed and switched to medium D that remains unknown. INSIG-1 contains a putative ER
containing 1 g/ml of 25-HC plus 10 g/ml of cholesterol. After retention/retrieved signal, RRR, (Zerangue et al., 1999) at
incubation for 4 hr, cells were harvested and detergent-solubilized
residues 18–20. This signal is not present in the shorterextracts were prepared and subjected to immunoprecipitation as
version of INSIG-1 that begins at residue 37 (Figuredescribed in Supplemental Experimental Procedures available
1A). When we transfected a cDNA encoding this shorterat http://www.cell.com/cgi/content/full/110/4/489/DC1. For pre-
clearing, 30 g of an IgG fraction of nonimmune rabbit serum was version into SRD-13A cells, it showed the same activity
used. For immunoprecipitation, the following antibodies were used: as did the longer version of INSIG-1 in inhibiting SREBP
30 g of nonimmune IgG for control antibody (Ab), 30 g of anti- cleavage, indicating that the RRR motif is not essential
SCAP IgG-R139, or 5 g of polyclonal anti-Myc IgG (INSIG-1). Equal for the function of INSIG-1 (data not shown).
fractions of supernatant (S) and immunoprecipitated pellets (P) (rep-
Certain kinetic features of the SCAP/INSIG-1 interac-resenting 0.5 dish of cells) were subjected to SDS-PAGE and immu-
tion might explain the finding that overexpression ofnoblot analysis with 67 ng/ml anti-HSV IgG (SREBP), 5 g/ml anti-
INSIG-1 increases the sensitivity of SCAP to inhibitionSCAP IgG-9D5, or 1g/ml anti-Myc IgG-9E10 (INSIG-1) as indicated.
Filters were exposed to film for 10 s for all blots except for those by sterols (Figure 7). If the sterol/SCAP interaction is
against SCAP, which were exposed for 20 s. readily reversible, but the sterol/SCAP/INSIG-1 interac-
tion is irreversible, then high levels of INSIG-1 would
pull the reaction in favor of the SCAP/INSIG-1 complex
increased when cultured rat H35 hepatoma cells were at any given level of sterol. This would have the effect
treated with insulin. The mechanism for this induction of increasing the apparent affinity of the reaction for
and the function of the protein were unknown. In 1998, sterol as shown in Figure 7.
our laboratory encountered INSIG-1 as a gene that was Although we have not yet been able to measure the
upregulated in livers of transgenic mice that overex- kinetics of SCAP/INSIG-1 binding, the current data lend
pressed an active version of SREBP-1a and SREBP-2, some support to the possibility of an irreversible interac-
and we showed that INSIG-1 mRNA is regulated in paral- tion of SCAP and INSIG-1. This interaction persists when
lel with nuclear SREBPs in liver and in cultured cells the complex has been solubilized with digitonin in prep-
when nuclear SREBP-1a and SREBP-2 levels were made aration for BN-PAGE (Figure 4), with Chapso as in the
to vary by sterol deprivation and readdition (Luong, original isolation of the complex or with Nonidet P40
2000). (Figure 8). Digitonin causes sterols to precipitate out of
solution, and the other two detergents would be ex-Here, through the use of BN-PAGE, we show that
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interacting proteins, transfection of mammalian cells, Northern blotpected to strip them from the SCAP/INSIG-1 complex.
analysis, immunoblot analysis, and immunoprecipitation) may beIt is possible that this complex binds sterols so tightly
found as Supplemental Experimental Procedures available at http://that they cannot be removed by these perturbing agents.
www.cell.com/cgi/content/full/110/4/489/DC1.
Alternatively, once the SCAP/INSIG-1 interaction has
been triggered by sterols, it might persist even when Tissue Culture Media
sterols are removed. Other explanations for these data Medium A contains Dulbecco’s modified Eagle medium, 10% (v/v)
cannot be ruled out. For example, it is possible that fetal calf serum (FCS), 100 U/ml penicillin, and 100 g/ml streptomy-
cin sulfate.INSIG-1 presents sterols to SCAP and thereby facilitates
Medium B contains HyQ SFX-MAb complete serum-free mediumSCAP/INSIG-1 binding, or that sterols activate INSIG-1
supplemented with 10% FCS, 10 mM L-glutamine, 100 U/ml penicil-by enhancing covalent modification of one of the partici-
lin, and 100 g/ml streptomycin sulfate.
pants in the complex. These questions will only be re- Medium C contains 1:1 mixture of Ham’s F-12 medium and Dul-
solved when the sterol effect on SCAP/INSIG-1 binding becco’s modified Eagle’s medium containing 100 U/ml penicillin
can be measured by more precise techniques in vitro. and 100 g/ml streptomycin sulfate.
Medium D is medium C supplemented with 5% lipoprotein-defi-When the ratio of INSIG-1 to SCAP is high, INSIG-1
cient serum, 50 M compactin, and 50 M sodium mevalonate.can block SREBP processing even in the absence of
added exogenous sterols (Figures 2 and 3A). It is possi-
Plasmidsble that this reflects a sterol-independent interaction of
The following recombinant expression plasmids were previously
INSIG-1 with SCAP that is of low affinity, but is driven described: pTK-HSV-BP-1a and pTK-HSV-BP-2, encoding wild-type
by the high INSIG-1 concentration. We cannot rule out HSV-tagged human SREBP-1a and SREBP-2, respectively, under
the possibility that the high levels of INSIG-1 create a control of the weak thymidine kinase (TK) promoter (Hua et al.,
1996b); pTK-SCAP and pTK-SCAP(Y298C), encoding wild-type andsituation in which low levels of endogenous sterols can
mutant hamster SCAP, respectively (Nohturfft et al., 1998a); pCMV-trigger SCAP binding to INSIG-1 without the necessity
SCAP and pCMV-SCAP(Y298C), encoding wild-type and mutantfor exogenous sterols.
hamster SCAP, respectively, under control of the strong cytomega-
An important observation in the current studies is that lovirus (CMV) promoter (Sakai et al., 1997); and pCMV-VSVG-T7,
mutant SCAP(Y298C) binds INSIG-1 much less well than encoding T7-tagged VSVG protein from the ts045 mutant strain of
wild-type SCAP, even in the presence of high sterol vesicular stomatitis virus under control of CMV promoter (Nohturfft
et al., 2000).levels (Figure 6C). Moreover, INSIG-1 was unable to
Construction of the following recombinant expression plasmidsprevent SCAP(Y298C) from facilitating SREBP-2 pro-
are described in detail in Supplemental Experimental Procedurescessing in the absence of added sterols (Figure 6A) or
available at above URL. pCMV-CBP-FLAG-SCAP(TM1-6)-Myc and
in the presence of sterols (Figure 6B). In experiments to pCMV-CBP-FLAG-SCAP(TM1-5)-Myc encode, 5 to 3, a CBP tag
be reported elsewhere (Brown et al., 2002), we show (calmodulin binding peptide tag); a FLAG tag; amino acids 1–448
that the Y298C mutant of SCAP is resistant to the sterol- (first 6 transmembrane domains) or 1–415 (first 5 transmembrane
domains) of hamster SCAP (Hua et al., 1996a), respectively; andmediated conformational change in SCAP as measured
three copies of a c-Myc tag. pCMV-INSIG-1-Myc encodes aminoby the tryptic cleavage assay (see above Discussion).
acids 1–277 of human INSIG-1, followed by six tandem copies of aIf sterol binding to SCAP is required to convert SCAP
c-Myc epitope tag.
to a form in which it binds INSIG-1, then the Y298C
mutant might be defective either because it does not
Identification of SCAP-Interacting Proteins
bind sterols or because it binds sterols but it cannot Stably transfected human 293S cells (Reeves et al., 1996) expressing
undergo the conformational change necessary to bind SCAP(TM1-6) and SCAP(TM1-5) were generated as described in
Supplemental Experimental Procedures available at above URL.INSIG-1.
293S/SCAP(TM1-6) and 293S/SCAP(TM1-5) cells were grown in sus-The TM1-6 fragment of SCAP that binds INSIG-1 in-
pension for 5 days in medium B at 37C (without CO2). On day 6,cludes the sterol-sensing domain, TM2-6. Sequences
each cell line received 1 g/ml 25-HC, was incubated for 24 hr, andresembling the sterol-sensing domain are found in three
then harvested. The 1000 g pellet of cells was washed once with
other proteins: 3-hydroxy-3-methylglutaryl coenzyme A phosphate-buffered saline (PBS) and frozen at 80C until use.
reductase (HMG CoA reductase), a rate-limiting enzyme All subsequent operations were carried out on ice or at 4C. Each
thawed cell pellet (representing 10 liters of 293S/SCAP(TM1-5) cellsin cholesterol synthesis; Niemann-Pick C1 protein,
or 6 liters of 293S/SCAP(TM1-6) cells) was incubated at 4C for 30which participates in the intracellular movement of cho-
min with buffer containing 50 mM HEPES-KOH [pH 7.4], 1.5 mMlesterol; and Patched, the receptor for Hedgehog, a pro-
MgCl2, 10 mM KCl, 250 mM sucrose, 5 mM sodium EDTA, 5 mMtein that contains covalently bound cholesterol (re-
sodium EGTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 10
viewed in Brown and Goldstein, 1999). It is tempting g/ml leupeptin. Cells were lysed with 30 strokes of a Dounce ho-
to speculate that the sterol-sensing domain in these mogenizer. Each cell lysate was centrifuged at 1000 g for 5 min to
proteins also binds INSIG-1 or a related protein. Mam- remove nuclei and unlysed cells. Each supernatant was centrifuged
at 10,000 g for 15 min to isolate a membrane fraction, which wasmalian genomes contain one other protein, designated
solubilized with buffer A (50 mM HEPES-KOH [pH 7.4], 150 mMINSIG-2 (GenBank Acession Number XM_043953),
NaCl, 0.5% (w/v) Chapso, 1 mM PMSF, and 10 g/ml of leupeptin).whose amino acid sequence is 70% identical to that of
After incubation for 1 hr, the insoluble material was removed by
INSIG-1. Whether INSIG-2 can bind SCAP, or whether centrifugation at 105 g for 30 min. The supernatant was incubated
INSIG-1 and/or INSIG-2 can interact with other proteins with an irrelevant control mouse monoclonal antibody IgG-2001
that contain sterol-sensing domains remains to be de- (Tolleshaug et al., 1982) and Protein G Sepharose 4 beads for 1 hr.
The supernatant was bound to anti-FLAG-M2 Agarose Affinity Geltermined.
in batch, and the suspension of beads was rotated for 3 hr. The
beads were washed 5 times (10 min each) with buffer containing 50Experimental Procedures
mM HEPES-KOH [pH 7.4], 150 mM NaCl, and 0.2% Chapso, after
which the proteins captured by the affinity resin were eluted for 12Materials used in this study and methods (cDNA cloning of INSIG-1,
construction of expression plasmids, LC-MS/MS analysis of SCAP hr with buffer A containing 0.25 mg/ml of FLAG peptide. Each eluate
Sterols Promote Interaction of SCAP with INSIG-1
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was adjusted to a final concentration of 2 mM CaCl2 and applied to Brown, M.S., and Goldstein, J.L. (1999). A proteolytic pathway that
controls the cholesterol content of membranes, cells, and blood.calmodulin affinity resin in batch for 2 hr, after which each resin
was washed 3 times (10 min each) with buffer containing 50 mM Proc. Natl. Acad. Sci. USA 96, 11041–11048.
HEPES-KOH [pH 7.4], 0.5 M NaCl, 0.2% Chapso, and 2 mM CaCl2. Brown, M.S., Ye, J., Rawson, R.B., and Goldstein, J.L. (2000). Regu-
Proteins were eluted for 1 hr in buffer containing 50 mM HEPES- lated intramembrane proteolysis: a control mechanism conserved
KOH [pH 7.4], 0.3 M NaCl, 2 mM sodium EGTA, and 0.5% Chapso. from bacteria to humans. Cell 100, 391–398.
Each eluate was precipitated overnight at 80C with 5 volumes of
Brown, A.J., Sun, L., Feramisco, J.D., Brown, M.S., and Goldstein,
cold acetone and centrifuged at 20,000 g for 10 min. Each pellet
J.L. (2002). Cholesterol addition to ER membranes alters conforma-
was dried and resuspended at room temperature in 80 l of buffer
tion of SCAP, the SREBP escort protein that regulates cholesterol
containing 50 mM Tris-HCl [pH 7.4], 150 mM NaCl, and 1% (w/v) SDS.
metabolism. Mol. Cell, in press.
The proteins were subjected to SDS-PAGE on 12% gels, visual-
DeBose-Boyd, R.A., Brown, M.S., Li, W.-P., Nohturfft, A., Goldstein,ized with Coomassie blue stain, and processed for liquid chromatog-
J.L., and Espenshade, P.J. (1999). Transport-dependent proteolysisraphy-tandem mass spectrometry (LC-MS/MS) analysis as de-
of SREBP: relocation of site-1 protease from Golgi to ER obviatesscribed in Supplemental Experimental Procedures available at
the need for SREBP transport to Golgi. Cell 99, 703–712.http://www.cell.com/cgi/content/full/110/4/489/DC1.
Diamond, R.H., Du, K., Lee, V.M., Mohn, K.L., Haber, B.A., Tewari,
D.S., and Taub, R. (1993). Novel delayed-early and highly insulin-Blue Native-PAGE for Detection of SCAP/INSIG-1 Complex
induced growth response genes: identification of HRS, a potentialBlue native-PAGE (BN-PAGE) was carried out as described by
regulator of alternative pre-mRNA splicing. J. Biol. Chem. 268,Schagger et al. (1994). A 16,000 g membrane pellet from transfected
15185–15192.SRD-13A cells was isolated in buffer containing 50 mM HEPES-
KOH [pH 7.2], 250 mM sorbitol, 70 mM potassium acetate, 5 mM Goldstein, J.L., Rawson, R.B., and Brown, M.S. (2002). Mutant mam-
sodium EGTA, and 1.5 mM magnesium acetate as described (Noh- malian cells as tools to delineate the sterol regulatory element-
turfft et al., 2000). In the standard assay for detection of SCAP/ binding protein pathway for feedback regulation of lipid synthesis.
INSIG-1 complex, aliquots of the membranes (50 g protein in 100 Arch. Biochem. Biophys. 397, 139–148.
l) were mixed with 100 l of buffer containing 40 mM HEPES-KOH Hua, X., Nohturfft, A., Goldstein, J.L., and Brown, M.S. (1996a). Sterol
[pH 7.0], 2 mM magnesium acetate, and 2% (w/v) digitonin in a final resistance in CHO cells traced to point mutation in SREBP cleavage
volume of 200 l. After incubation at 4C for 30 min, detergent- activating protein (SCAP). Cell 87, 415–426.
insoluble material was removed by centrifugation at 20,000 g for 2
Hua, X., Sakai, J., Brown, M.S., and Goldstein, J.L. (1996b). Regu-min at 4C. One aliquot of the supernatant (90 l) was mixed with
lated cleavage of sterol regulatory element binding proteins10 l of buffer containing 50 mM Bis-Tris-HCl [pH 7.0], 0.75 M
(SREBPs) requires sequences on both sides of the endoplasmic6-amino-n-hexanoic acid, 5% (w/v) Coomassie G250, and 10% (v/v)
reticulum membrane. J. Biol. Chem. 271, 10379–10384.glycerol; loaded onto a 4%–16% BN gel; and subjected to PAGE
Kyte, J., and Doolittle, R.F. (1982). A simple method for displaying(Schagger et al., 1994). After electrophoresis, proteins were trans-
the hydropathic character of a protein. J. Mol. Biol. 157, 105–132.ferred electrophoretically to a PVDF membrane (Millipore Corp.),
destained with methanol, and subjected to immunoblot analysis Laemmli, U.K. (1970). Cleavage of structural proteins during the
with 0.33 g/ml of polyclonal anti-Myc IgG directed against epitope- assembly of the head of bacteriophage T4. Nature 227, 680–685.
tagged INSIG-1. A separate 40 l aliquot of the digitonin-containing Lippincott-Schwartz, J., Yuan, L.C., Bonifacino, J.S., and Klausner,
supernatant was mixed with 10 l of 5X Laemmli buffer (Laemmli, R.D. (1989). Rapid redistribution of Golgi proteins into the ER in
1970) and subjected to SDS-PAGE on 8% and 12% gels for immu- cells treated with brefeldin A: evidence for membrane cycling from
noblot analysis of SCAP and epitope-tagged INSIG-1, respectively. Golgi to ER. Cell 56, 801–813.
For antibody supershift assays, a 50 l aliquot of membranes (10
Luong, A. (2000). Identification of three novel SREBP-activated tar-g) was added to 50 l of the above digitonin-containing buffer
get genes: Acetyl CoA Synthetase, 3--Hydroxysterol Dehydroge-together with 2 g of monoclonal antibody (control Ig-2001 or anti-
nase, and CL-6/INSIG1. Ph.D. Dissertation, University of TexasSCAP IgG-9D5, added in 2 l). The mixture was incubated at 4C
Southwestern Medical Center at Dallas, Dallas, Texas, p. 1–137.for 30 min and processed for BN-PAGE.
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